Thursday, December 16, 2021

US weighs J&J vaccine risks amid rise if clotting cases

US health officials at the Centers for Disease Control and Prevention
are weighing up the risks of Johnson & Johnson's Covid-19 vaccine,
following more cases of a blood clotting reaction.

It comes as a rise in coronavirus cases, and the threat of the new
Omicron variant, forces some schools and colleges to close and move
online.

Nick Harper reports from Washington.

IN: "A CDC..."
OUT: "...campus."
DUR: 45 seconds

https://fsnradionews.com/feeds/1216covid-nh.mp3